Nadroparin Calcium



Indications and Reactions:

Role Indications Reactions
Secondary
Myocardial Infarction 20.5%
Deep Vein Thrombosis 13.6%
Extradural Abscess 13.6%
Anticoagulant Therapy 9.1%
Pemphigus 9.1%
Arteriogram Coronary 6.8%
Dyspnoea 6.8%
Renal Cell Carcinoma 6.8%
Peripheral Ischaemia 4.5%
Depression 2.3%
Essential Hypertension 2.3%
Hyperlipidaemia 2.3%
Psoriasis 2.3%
Thrombocytopenia 20.0%
Urosepsis 20.0%
Haematuria 13.3%
Visual Impairment 13.3%
Abdominal Pain 6.7%
Hypersensitivity 6.7%
Pulmonary Embolism 6.7%
Tachycardia 6.7%
Urticaria 6.7%
Concomitant
Drug Use For Unknown Indication 17.5%
Prophylaxis 14.5%
Hypertension 11.8%
Product Used For Unknown Indication 10.2%
Thrombosis Prophylaxis 6.1%
Prophylaxis Of Nausea And Vomiting 4.7%
Abdominal Pain 3.5%
Colorectal Cancer 3.1%
Breast Cancer 2.9%
Non-small Cell Lung Cancer 2.9%
Acute Myeloid Leukaemia 2.7%
Plasma Cell Myeloma 2.5%
Small Cell Lung Cancer Stage Unspecified 2.5%
Pyrexia 2.4%
Bronchitis 2.2%
Chest Pain 2.2%
Colorectal Cancer Metastatic 2.2%
Rheumatoid Arthritis 2.2%
Multiple Myeloma 2.0%
Non-small Cell Lung Cancer Stage Iv 2.0%
Renal Failure Acute 13.4%
Pneumonitis 9.0%
Sepsis 9.0%
Pneumonia 6.0%
Fungal Infection 4.5%
Haematuria 4.5%
Muscular Weakness 4.5%
Pyrexia 4.5%
Rash 4.5%
Retinal Vein Thrombosis 4.5%
Rhabdomyolysis 4.5%
Tumour Necrosis 4.5%
Weight Decreased 4.5%
Wound Infection 4.5%
Alanine Aminotransferase Increased 3.0%
Bacteria Urine 3.0%
Brain Oedema 3.0%
Deafness Bilateral 3.0%
Diabetes Mellitus 3.0%
Diverticulitis 3.0%
Interacting
Hypertension 26.7%
Type 2 Diabetes Mellitus 20.0%
Pain 15.6%
Bacterial Infection 13.3%
Acute Myocardial Infarction 4.4%
Antiplatelet Therapy 4.4%
Ischaemic Stroke 4.4%
Product Used For Unknown Indication 4.4%
Deep Vein Thrombosis 2.2%
Infection 2.2%
Prophylaxis 2.2%
Drug Interaction 44.4%
Condition Aggravated 11.1%
Haematoma 11.1%
Hypoglycaemic Coma 11.1%
Intra-abdominal Haematoma 11.1%
Peripheral Artery Thrombosis 11.1%